74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
V Vitrolife AB
V
Open
164.8 1.79
Overview
Share price change
24h
Min
158.6
Max
164.7
Income | 27M 182M |
|---|---|
Sales | 92M 959M |
P/E Sector Avg | 44.736 73.239 |
EPS | 1.02 |
Dividend yield | 0.59 |
Profit margin | 18.978 |
Employees | 1,120 |
EBITDA | 52M 225M |
Dividend yield Sector Avg | 0.59% 3.06% |
|---|---|
Next Earnings | 24 Apr 2025 |
Market Cap | 23B |
|---|---|
Previous open | 163.01 |
Previous close | 164.8 |
Vitrolife AB Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Vitrolife AB Forecast
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Vitrolife AB
Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.
